Friday 27th January 2012 |
Text too small? |
Huljich Wealth Management accounts reveal the KiwiSaver fund management company associated with politicians John Banks and Don Brash was sold to Fisher Funds for $20.9 million.
Fisher Funds said in March last year the Huljich KiwiSaver Scheme would be transferred to the Fisher Funds KiwiSaver Scheme, making Fisher Funds one of the largest non-default KiwiSaver schemes in the country.
Huljich Wealth Management was set up in 2007 by Peter Huljich, ACT MP Banks and former National Party and former ACT leader Brash.
In 2010, Huljich stepped down as managing director amid mounting criticism he had topped up funds from his personal resources in a way that artificially boosted their performance figures. He later pleaded guilty to a charge of misleading investors and was fined almost $113,000.
The accounts for the 14 months to May 31, 2011 filed to the Companies Office show share capital of $1,000 and retained earnings of $9.6 million.
Final approval of the sale was received on May 17 and about 87,000 eligible Huljich KiwiSaver members with entitlements of $191 million were transferred to the Fisher Funds KiwiSaver Scheme.
The business sold to Fisher Funds was the majority of the company’s operations. It retained responsibility to collect debtors and realise payables under the terms of the sale.
The proceeds of $20.9 million were reduced by a $4.29 million write-off of fees, by stamp duty and losses on vehicles sold. This left a gain on the disposal of the business of $16.53 million.
The accounts show other income of $17.2 million, including the proceeds, and just $5.34 million of operating revenue.
The business made a profit of $13.5 million in the 14 months to May 31, 2011 compared to a loss of $771,737 last year.
(BusinessDesk)
BusinessDesk.co.nz
No comments yet
December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors